Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noncompartmentally-based pharmacokinetic modeling.

P Veng-Pedersen1

  • 1University of Iowa, College of Pharmacy, S227, Iowa City, IA 52242, USA. veng@uiowa.edu

Advanced Drug Delivery Reviews
|May 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bayesian population analysis of the development of type 2 diabetes in the offspring of diabetic parents.

Journal of pharmacokinetics and pharmacodynamics·2011
Same author

The effect of anticoagulant, storage temperature and dilution on cord blood hematology parameters over time.

International journal of laboratory hematology·2008
Same author

Change in erythropoietin pharmacokinetics following hematopoietic transplantation.

Clinical pharmacology and therapeutics·2007
Same author

Individualized pharmacokinetic risk assessment for development of diabetes in high risk population.

Diabetes research and clinical practice·2007
Same author

Urinary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm neonates.

Journal of perinatology : official journal of the California Perinatal Association·2006
Same author

A 'bottom-up' approach for endo-PK/PD analysis.

Biopharmaceutics & drug disposition·2006
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
Same journal

Human organ-on-a-chip technology as a catalyst for drug discovery.

Advanced drug delivery reviews·2026
See all related articles

Linear systems analysis (LSA) offers powerful, underutilized tools for pharmacokinetic (PK) modeling. These methods, based on molecular stochastic independence (MSI), provide a rational alternative to traditional approaches for drug analysis.

Area of Science:

  • Pharmacokinetics and Systems Pharmacology
  • Mathematical Modeling in Drug Development

Background:

  • Traditional pharmacokinetic (PK) modeling often relies on complex, structured compartmental models.
  • These models can involve numerous assumptions and may not fully capture system dynamics.

Purpose of the Study:

  • To provide an overview of noncompartmentally-based modeling, emphasizing linear systems analysis (LSA).
  • To highlight the utility of LSA in PK predictions and drug disposition evaluations.

Main Methods:

  • Utilizing fundamental elements of LSA with a linear operational viewpoint, grounded in molecular stochastic independence (MSI).
  • Applying powerful LSA procedures like convolution, deconvolution, and disposition decomposition analysis (DDA).
  • DDA nonparametrically differentiates the unit impulse response (UIR) into elimination and distribution functions.

Related Experiment Videos

Main Results:

  • LSA procedures enable PK predictions and evaluations of drug input/delivery with simple models and few assumptions.
  • DDA facilitates nonparametric analysis of drug elimination, distribution, and mean time parameters.
  • LSA offers a rational alternative to structured modeling for multivariate PK systems.

Conclusions:

  • Linear systems analysis (LSA) provides a robust and versatile toolkit for kinetic analysis.
  • These underutilized LSA-based methods offer a powerful alternative to conventional kinetic modeling approaches.